Literature DB >> 9461561

Control of initiation of viral plus strand DNA synthesis by HIV reverse transcriptase.

C Palaniappan1, J K Kim, M Wisniewski, P J Fay, R A Bambara.   

Abstract

Human immunodeficiency virus reverse transcribes its single-stranded RNA genome making a DNA copy. As synthesis proceeds, the RNA is simultaneously degraded to oligomers; one of these, the polypurine tract, primes synthesis of a plus strand DNA. The viral reverse transcriptase (RT) degrades all of the non-polypurine tract oligomers. We show that unlike other DNA polymerases the retroviral RT can bind either end of an annealed RNA primer, the 5'-end for degradation and the 3'-end for synthesis. The competition between the two binding modes at any primer determines whether it will be extended or degraded. The 5'-end binding can be suppressed in at least two ways. The sequence of the primer can be such that a region at the 5'-end is unannealed or a DNA primer can be annealed just adjacent to the 5'-end of the RNA primer. This promotes binding of RT to the RNA 3'-end, allowing a primer that would normally be degraded to be extended. Implications for human immunodeficiency virus replication and antiviral therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461561     DOI: 10.1074/jbc.273.7.3808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

4.  Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein.

Authors:  L Hameau; J Jeusset; S Lafosse; D Coulaud; E Delain; T Unge; T Restle; E Le Cam; G Mirambeau
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.

Authors:  P Gerondelis; R H Archer; C Palaniappan; R C Reichman; P J Fay; R A Bambara; L M Demeter
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture.

Authors:  R H Archer; C Dykes; P Gerondelis; A Lloyd; P Fay; R C Reichman; R A Bambara; L M Demeter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.

Authors:  Chandravanu Dash; Jason W Rausch; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

8.  A new role for HIV nucleocapsid protein in modulating the specificity of plus strand priming.

Authors:  Deena T Jacob; Jeffrey J DeStefano
Journal:  Virology       Date:  2008-07-15       Impact factor: 3.616

Review 9.  Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.

Authors:  Nicolas Sluis-Cremer; Gilda Tachedjian
Journal:  Virus Res       Date:  2008-03-26       Impact factor: 3.303

10.  Fidelity of plus-strand priming requires the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.

Authors:  Klara Post; Besik Kankia; Swathi Gopalakrishnan; Victoria Yang; Elizabeth Cramer; Pilar Saladores; Robert J Gorelick; Jianhui Guo; Karin Musier-Forsyth; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2009-01-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.